CVE-2025-0416
HIGHCVSS Vector
CVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:N/AU:Y/R:U/V:D/RE:H/U:Amber
Lifecycle Timeline
2Description
Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.
Analysis
Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. Rated high severity (CVSS 8.9), this vulnerability is low attack complexity. No vendor patch available.
Technical Context
This vulnerability is classified as Improper Privilege Management (CWE-269), which allows attackers to escalate privileges to gain unauthorized elevated access. Local privilege escalation through insecure DCOM configuration in Valmet DNA versions prior to C2023. The DCOM object Valmet DNA Engineering has permissions that allow it to run commands as a user with the SeImpersonatePrivilege privilege. The SeImpersonatePrivilege privilege is a Windows permission that allows a process to impersonate another user. An attacker can use this vulnerability to escalate their privileges and take complete control of the system.
Affected Products
Valmet DNA versions.
Remediation
No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply principle of least privilege, validate privilege transitions, implement proper role separation.
Priority Score
Share
External POC / Exploit Code
Leaving vuln.today